The Tiny Cargo Company
- Academic, tech transfer
- Biotech or pharma, therapeutic R&D
The Tiny Cargo Company is a pioneering biotechnology firm specializing in developing exosome-based drug delivery platforms. By harnessing the natural properties of milk-derived extracellular vesicles (mEVs) and leveraging its proprietary intellectual property, the company aims to revolutionize the delivery of complex therapeutics, including peptides, monoclonal antibodies (mAbs), GLP-1 receptor agonists, and CRISPR gene-editing tools.
To advance these objectives, Tiny Cargo is establishing the world's first large-scale manufacturing facility dedicated to isolating and purifying milk exosomes.
This initiative focuses on creating versatile and scalable platforms to facilitate the next generation of biologic therapies.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}